Pfm Health Sciences, LP Adaptimmune Therapeutics PLC Transaction History

Pfm Health Sciences, LP

$1.95 Billion
Q2 2024

A detailed history of Pfm Health Sciences, LP transactions in Adaptimmune Therapeutics PLC stock. As of the latest transaction made, Pfm Health Sciences, LP holds 10,520,231 shares of ADAP stock, worth $7.78 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

10,520,231

Previous 10,423,135 0.93%

Holding current value

$7.78 Million

Previous $16.5 Million 37.4%

% of portfolio

0.53%

Previous 0.81%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.83 - $1.47 $80,589 - $142,731	97,096 Added 0.93%	10,520,231 $10.3 Million
Q3 2023 Nov 14, 2023	BUY	$0.73 - $1.04 $1.51 Million - $2.15 Million	2,065,893 Added 24.72%	10,423,135 $8.13 Million
Q2 2023 Aug 14, 2023	BUY	$0.9 - $1.51 $2.13 Million - $3.57 Million	2,364,671 Added 39.46%	8,357,242 $7.69 Million
Q1 2023 May 15, 2023	BUY	$1.06 - $2.16 $1.22 Million - $2.48 Million	1,149,061 Added 23.72%	5,992,571 $6.53 Million
Q4 2022 Feb 14, 2023	SELL	$1.05 - $2.53 $4.7 Million - $11.3 Million	-4,477,074 Reduced 48.03%	4,843,510 $7.07 Million
Q3 2022 Nov 14, 2022	BUY	$1.06 - $2.41 $223,452 - $508,037	210,804 Added 2.31%	9,320,584 $10 Million
Q2 2022 Aug 15, 2022	BUY	$1.33 - $2.28 $8.96 Million - $15.4 Million	6,735,106 Added 283.62%	9,109,780 $15.5 Million
Q1 2022 May 16, 2022	SELL	$1.73 - $4.06 $1.43 Million - $3.36 Million	-826,392 Reduced 25.82%	2,374,674 $4.89 Million
Q4 2021 Feb 14, 2022	SELL	$3.5 - $5.68 $4.21 Million - $6.83 Million	-1,202,508 Reduced 27.31%	3,201,066 $12 Million
Q3 2021 Nov 15, 2021	BUY	$3.44 - $6.37 $2.67 Million - $4.94 Million	775,674 Added 21.38%	4,403,574 $22.8 Million
Q2 2021 Aug 16, 2021	BUY	$3.86 - $5.78 $4.35 Million - $6.51 Million	1,126,597 Added 45.04%	3,627,900 $15.5 Million
Q1 2021 May 17, 2021	SELL	$4.9 - $6.83 $947,983 - $1.32 Million	-193,466 Reduced 7.18%	2,501,303 $13.3 Million
Q4 2020 Feb 16, 2021	BUY	$4.0 - $9.2 $7.38 Million - $17 Million	1,845,329 Added 217.24%	2,694,769 $14.5 Million
Q3 2020 Nov 16, 2020	BUY	$7.66 - $10.78 $6.51 Million - $9.16 Million	849,440 New	849,440 $6.78 Million

Others Institutions Holding ADAP

# of Institutions

Shares Held

152M

Call Options Held

78.5K

Put Options Held

36.5K

View Full List

About Adaptimmune Therapeutics PLC

Ticker ADAP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 163,370,000
Market Cap $121M
Description
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...

More about ADAP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pfm Health Sciences, LP with notifications on news.

Account

Pfm Health Sciences, LP Adaptimmune Therapeutics PLC Transaction History